hero image
Dr. Eva Polverino - International Federation on Ageing. Barcelona, , ES

Dr. Eva Polverino Dr. Eva Polverino

Secretary | European Respiratory Society

Barcelona, SPAIN

Dr. Eva Polverino specializes in the area of pulmonary diseases.

Media

Publications:

Documents:

Photos:

Eva Polverino loading image Eva Polverino loading image

Videos:

Audio:

Social

Biography

Dr. Eva Polverino is a pulmonologist expert in respiratory infections affiliated with the European Respiratory Society.

Industry Expertise (3)

Research Medical/Dental Practice Education/Learning

Areas of Expertise (3)

Research Medicine Pulmonary Diseases

Education (1)

University of Pisa: M.D., Medicine, Pulmonary Disease Residency Program 2002

Affiliations (1)

  • European Respiratory Society

Languages (1)

  • English

Featured Articles (5)

Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomize... American Medical Association

2015

Importance In patients with severe community-acquired pneumonia, treatment failure is associated with excessive inflammatory response and worse outcomes. Corticosteroids may modulate cytokine release in these patients, but the benefit of this adjunctive therapy remains controversial.

view more

Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study European Respiratory Journal

2013

This phase II, randomised, double-blind, multicentre study (NCT00930982) investigated the safety and efficacy of ciprofloxacin dry powder for inhalation (DPI) in patients with non-cystic fibrosis bronchiectasis.

view more

Microbial aetiology of community-acquired pneumonia and its relation to severity BMJ Journals Thorax

2011

The distribution of the microbial aetiology and mortality of community-acquired pneumonia (CAP) was investigated in relation to the clinical setting and severity scores (pneumonia severity index (PSI) and confusion, blood urea nitrogen, respiratory rate, blood pressure, age (CURB-65).

view more

Managing passengers with stable respiratory disease planning air travel: British Thoracic Society recommendations BMJ Journals Thorax

2011

Since the first British Thoracic Society (BTS) recommendations published in 2002 and web update in 2004, data from several studies have confirmed previous findings suggesting that neither resting sea level oxygen saturations nor forced expiratory volume in 1 s (FEV1) reliably predict hypoxaemia or complications of air travel in passengers with respiratory disease. It is thus now clear that there is no reliable threshold in these variables to determine accurately the safety of air travel or need for in-flight oxygen in an individual patient. Nevertheless, the need for practical recommendations remains. The new guidance covers bronchiectasis, cancer, hyperventilation and dysfunctional breathing, obesity, pulmonary arteriovenous malformations and sinus and middle ear disease, and has expanded sections on infection and comorbidity with cardiac disease.

view more

Severe Community-Acquired Pneumonia: Validation of the Infectious Diseases Society of America/American Thoracic Society Guidelines to Predict an Intensive Care Unit Admission Clinical Infectious Diseases

2009

The recent Infectious Disease Society of America/American Thoracic Society guidelines for the management of community-acquired pneumonia (CAP) in adults defined a predictive rule to identify patients with severe CAP to determine the need for intensive care unit (ICU) admission. We clinically validated this rule.

view more

Contact